Loading...
Blade's Q4 2024 revenue grew by 14.5% to $54.4 million, driven by strong performance in the Medical segment. Net loss improved by 71.1% to $9.8 million, and Adjusted EBITDA saw a substantial improvement, reaching near break-even at $(0.4) million. Flight profit increased by 39.7%, with a flight margin expansion to 23.2%.
Revenue increased 14.5% to $54.4 million.
Net loss improved 71.1% to $(9.8) million.
Flight profit grew 39.7% to $12.6 million.
Adjusted EBITDA improved to $(0.4) million from $(5.2) million last year.
Blade expects revenue between $245M and $265M in 2025, with projected double-digit Adjusted EBITDA growth.
Visualization of income flow from segment revenue to net income